The Leukemia & Lymphoma Society Launches Impact Research Grants To Help Underserved Patients Access Clinical Trials
Collaborations with Mayo Clinic, Vanderbilt University Medical Center and Weill Cornell Medicine will Increase Representation of Geographically, Ethnically and Economically Underserved Communities in Clinical Trials
News provided by
Share this article
RYE BROOK, N.Y., May 13, 2021 /PRNewswire/
The Leukemia & Lymphoma Society (LLS) announced today the launch of the IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants to increase enrollment of individuals from underrepresented communities in clinical trials. Clinical trials are vital to improving cancer treatment, giving newly diagnosed patients access to state-of-the-art therapies, and providing a lifeline when other treatments have failed. Yet, clinical trials overwhelmingly fail to represent certain patient populations such as ethnic and racial minorities and people in rural co
Press release content from PR Newswire. The AP news staff was not involved in its creation.
The Leukemia & Lymphoma Society Launches IMPACT Research Grants to Help Underserved Patients Access Clinical Trials
May 6, 2021 GMT
RYE BROOK, N.Y., May 6, 2021 /PRNewswire/ The Leukemia & Lymphoma Society (LLS) announced today the launch of the IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants to increase enrollment of individuals from underrepresented communities in clinical trials. Clinical trials are vital to improving cancer treatment, giving newly diagnosed patients access to state-of-the-art therapies, and providing a lifeline when other treatments have failed. Yet, clinical trials overwhelmingly fail to represent certain patient populations such as ethnic and racial minorities and people in rural communities.